{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:48:24Z","timestamp":1757623704630,"version":"3.44.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"publisher","award":["C0046"],"award-info":[{"award-number":["C0046"]}],"id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.rcsop.2022.100164","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T21:50:00Z","timestamp":1659477000000},"page":"100164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["A protocol for a randomized controlled trial comparing Sleepwell, EMPOWER, and treatment-as-usual for benzodiazepine receptor agonist discontinuation in older adults: the your answers when needing sleep in New Brunswick (YAWNS NB) study"],"prefix":"10.1016","volume":"7","author":[{"given":"Andrea L.","family":"Murphy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin P.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malgorzata","family":"Rajda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Magalhaes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen G.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"Government of Canada SC","key":"10.1016\/j.rcsop.2022.100164_bb0005"},{"author":"Canadian Institute for Health Information","key":"10.1016\/j.rcsop.2022.100164_bb0010"},{"author":"Canadian Institute for Health Information","key":"10.1016\/j.rcsop.2022.100164_bb0015"},{"author":"Canadian Deprescribing Network","key":"10.1016\/j.rcsop.2022.100164_bb0020"},{"key":"10.1016\/j.rcsop.2022.100164_bb0025","series-title":"Drug Use among Seniors in Canada, 2016","first-page":"1","author":"Canadian Institute of Health Information","year":"2018"},{"key":"10.1016\/j.rcsop.2022.100164_bb0030","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e8343","article-title":"Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the food and drug administration","volume":"345","author":"Huedo-Medina","year":"2012","journal-title":"BMJ."},{"issue":"2","key":"10.1016\/j.rcsop.2022.100164_bb0035","first-page":"225","article-title":"Meta-analysis of benzodiazepine use in the treatment of insomnia","volume":"162","author":"Holbrook","year":"2000","journal-title":"CMAJ"},{"issue":"2","key":"10.1016\/j.rcsop.2022.100164_bb0040","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsw044","article-title":"Effectiveness of benzodiazepine receptor agonists in the treatment of insomnia: an examination of response and remission rates","volume":"40","author":"Pillai","year":"2016","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.rcsop.2022.100164_bb0045","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5770\/cgj.23.419","article-title":"Canadian guidelines on benzodiazepine receptor agonist use disorder among older adults","volume":"23","author":"Conn","year":"2020","journal-title":"Can Geriatr J"},{"issue":"2","key":"10.1016\/j.rcsop.2022.100164_bb0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.7326\/M15-2175","article-title":"Clinical Guidelines Committee of the American College of Physicians. Management of Chronic Insomnia Disorder in adults: a clinical practice guideline from the American College of Physicians","volume":"165","author":"Qaseem","year":"2016","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.rcsop.2022.100164_bb0055","doi-asserted-by":"crossref","first-page":"103","DOI":"10.7326\/M15-1781","article-title":"Pharmacologic treatment of insomnia disorder: an evidence report for a clinical practice guideline by the American College of Physicians","volume":"165","author":"Wilt","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rcsop.2022.100164_bb0060","doi-asserted-by":"crossref","first-page":"15026","DOI":"10.1038\/nrdp.2015.26","article-title":"Insomnia disorder","volume":"1","author":"Morin","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"19","key":"10.1016\/j.rcsop.2022.100164_bb0065","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.2009.682","article-title":"Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial","volume":"301","author":"Morin","year":"2009","journal-title":"JAMA."},{"issue":"4","key":"10.1016\/j.rcsop.2022.100164_bb0070","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American Geriatrics Society 2019 updated AGS beers criteria\u00ae for potentially inappropriate medication use in older adults","volume":"67","author":"American Geriatrics Society","year":"2019","journal-title":"J Am Geriatr Soc"},{"author":"Canadian Geriatrics Society","key":"10.1016\/j.rcsop.2022.100164_bb0075"},{"issue":"2","key":"10.1016\/j.rcsop.2022.100164_bb0080","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ageing\/afu145","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2","volume":"44","author":"O\u2019Mahony","year":"2015","journal-title":"Age Ageing"},{"issue":"4","key":"10.1016\/j.rcsop.2022.100164_bb0085","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40268-017-0207-7","article-title":"Benzodiazepines and z-drugs: an updated review of major adverse outcomes reported on in epidemiologic research","volume":"17","author":"Brandt","year":"2017","journal-title":"Drugs R D"},{"issue":"4","key":"10.1016\/j.rcsop.2022.100164_bb0090","first-page":"577","article-title":"Assessing the cumulative effects of exposure to selected benzodiazepines on the risk of fall-related injuries in the elderly","volume":"24","author":"Sylvestre","year":"2012","journal-title":"IntPsychogeriatr."},{"issue":"1","key":"10.1016\/j.rcsop.2022.100164_bb0095","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00002512-200825010-00007","article-title":"Benzodiazepines and injurious falls in community dwelling elders","volume":"25","author":"Pariente","year":"2008","journal-title":"Drugs Aging"},{"issue":"11","key":"10.1016\/j.rcsop.2022.100164_bb0100","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2165\/00002512-200320110-00004","article-title":"The costs of benzodiazepine-associated hospital-treated fall injuries in the EU: a Pharmo study","volume":"20","author":"Panneman","year":"2003","journal-title":"Drugs Aging"},{"issue":"Journal Article","key":"10.1016\/j.rcsop.2022.100164_bb0105","doi-asserted-by":"crossref","first-page":"i90","DOI":"10.1136\/bmj.i90","article-title":"Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study","volume":"352","author":"Gray","year":"2016","journal-title":"BMJ"},{"issue":"Journal Article","key":"10.1016\/j.rcsop.2022.100164_bb0110","article-title":"Benzodiazepine use and risk of Alzheimer\u2019s disease: case-control study","volume":"349","author":"Billioti de Gage","year":"2014","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.rcsop.2022.100164_bb0115","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/pds.4028","article-title":"The association between benzodiazepines and influenza-like illness-related pneumonia and mortality: a survival analysis using UK primary care data","volume":"25","author":"Nakafero","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"14","key":"10.1016\/j.rcsop.2022.100164_bb0120","doi-asserted-by":"crossref","first-page":"E519","DOI":"10.1503\/cmaj.160126","article-title":"Risk of pneumonia associated with incident benzodiazepine use among community-dwelling adults with Alzheimer disease","volume":"189","author":"Taipale","year":"2017","journal-title":"CMAJ."},{"issue":"8","key":"10.1016\/j.rcsop.2022.100164_bb0125","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s40263-017-0445-9","article-title":"New, occasional, and frequent use of zolpidem or Zopiclone (alone and in combination) and the risk of injurious road traffic crashes in older adult drivers: a population-based case-control and case-crossover study","volume":"31","author":"Nevriana","year":"2017","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.rcsop.2022.100164_bb0130","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/gps.5048","article-title":"Benzodiazepines or related drugs and risk of pneumonia: a systematic review and meta-analysis","volume":"34","author":"Sun","year":"2019","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.rcsop.2022.100164_bb0135","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.aap.2016.08.001","article-title":"Medication use and the risk of motor vehicle collisions among licensed drivers: a systematic review","volume":"96","author":"Rudisill","year":"2016","journal-title":"Accid Anal Prev"},{"issue":"9","key":"10.1016\/j.rcsop.2022.100164_bb0140","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/j.1532-5415.2011.03561.x","article-title":"Psychoactive medications and crash involvement requiring hospitalization for older drivers: a population-based study","volume":"59","author":"Meuleners","year":"2011","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"10.1016\/j.rcsop.2022.100164_bb0145","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.mayocp.2016.07.024","article-title":"Benzodiazepine use in older adults: dangers, management, and alternative therapies","volume":"91","author":"Markota","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"10.1016\/j.rcsop.2022.100164_bb0150","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s40261-016-0397-8","article-title":"Benzodiazepine use, misuse, and harm at the population level in Canada: a comprehensive narrative review of data and developments since 1995","volume":"36","author":"Murphy","year":"2016","journal-title":"Clin Drug Investig"},{"issue":"12","key":"10.1016\/j.rcsop.2022.100164_bb0155","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","article-title":"Benzodiazepines revisited--will we ever learn?","volume":"106","author":"Lader","year":"2011","journal-title":"Addiction."},{"issue":"4","key":"10.1016\/j.rcsop.2022.100164_bb0160","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.amepre.2015.03.040","article-title":"Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines","volume":"49","author":"Jones","year":"2015","journal-title":"Am J Prev Med"},{"issue":"4","key":"10.1016\/j.rcsop.2022.100164_bb0165","first-page":"39","article-title":"Policies for deprescribing: an international scan of intended and unintended outcomes of limiting sedative-hypnotic use in community-dwelling older adults","volume":"14","author":"Shaw","year":"2019","journal-title":"Health Policy"},{"key":"10.1016\/j.rcsop.2022.100164_bb0170","article-title":"Brief interventions targeting long-term benzodiazepine and Z-drug use in primary care: a systematic review and meta-analysis","author":"Lynch","year":"2022","journal-title":"Addiction."},{"issue":"6","key":"10.1016\/j.rcsop.2022.100164_bb0175","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40266-018-0544-4","article-title":"Deprescribing benzodiazepines in older patients: impact of interventions targeting physicians, pharmacists, and patients","volume":"35","author":"Ng","year":"2018","journal-title":"Drugs Aging"},{"issue":"3","key":"10.1016\/j.rcsop.2022.100164_bb0180","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11606-006-0021-3","article-title":"Physicians\u2019 perspectives on prescribing benzodiazepines for older adults: a qualitative study","volume":"22","author":"Cook","year":"2007","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.rcsop.2022.100164_bb0185","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2296-3-9","article-title":"Long term benzodiazepine use for insomnia in patients over the age of 60: discordance of patient and physician perceptions","volume":"3","author":"Mah","year":"2002","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.rcsop.2022.100164_bb0190","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1471-2296-14-191","article-title":"General practitioners\u2019 experiences and perceptions of benzodiazepine prescribing: systematic review and meta-synthesis","volume":"14","author":"Sirdifield","year":"2013","journal-title":"BMC Fam Pract"},{"issue":"6","key":"10.1016\/j.rcsop.2022.100164_bb0195","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","article-title":"Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial","volume":"174","author":"Tannenbaum","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1016\/j.rcsop.2022.100164_bb0200","doi-asserted-by":"crossref","first-page":"e015959","DOI":"10.1136\/bmjopen-2017-015959","article-title":"A realist evaluation of patients\u2019 decisions to deprescribe in the EMPOWER trial","volume":"7","author":"Martin","year":"2017","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.rcsop.2022.100164_bb0205","first-page":"36","article-title":"Reducing benzodiazepine prescribing in older veterans: a direct-to-consumer educational brochure","volume":"35","author":"Mendes","year":"2018","journal-title":"Fed Pract"},{"issue":"5","key":"10.1016\/j.rcsop.2022.100164_bb0215","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/sleep\/34.5.601","article-title":"The insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment response","volume":"34","author":"Morin","year":"2011","journal-title":"Sleep."},{"issue":"6","key":"10.1016\/j.rcsop.2022.100164_bb0220","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep."},{"issue":"10","key":"10.1016\/j.rcsop.2022.100164_bb0225","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1016\/j.rcsop.2022.100164_bb0230","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1046\/j.1532-5415.2001.49281.x","article-title":"The vulnerable elders survey: a tool for identifying vulnerable older people in the community","volume":"49","author":"Saliba","year":"2001","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"10.1016\/j.rcsop.2022.100164_bb0235","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity","volume":"34","author":"Ware","year":"1996","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.rcsop.2022.100164_bb0240","doi-asserted-by":"crossref","DOI":"10.1080\/08870449908407311","article-title":"The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication","volume":"14","author":"Horne","year":"2020","journal-title":"Psychol Health"},{"issue":"3","key":"10.1016\/j.rcsop.2022.100164_bb0245","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/bjhp.12295","article-title":"Acceptability of health care interventions: a theoretical framework and proposed research agenda","volume":"23","author":"Sekhon","year":"2018","journal-title":"Br J Health Psychol"},{"author":"SPIRIT","key":"10.1016\/j.rcsop.2022.100164_bb0250"},{"key":"10.1016\/j.rcsop.2022.100164_bb0255","doi-asserted-by":"crossref","first-page":"g1687","DOI":"10.1136\/bmj.g1687","article-title":"Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide","volume":"348","author":"Hoffmann","year":"2014","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.rcsop.2022.100164_bb0260","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ijsu.2011.09.004","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"9","author":"Schulz","year":"2011","journal-title":"Int J Surg"},{"author":"MoCA - Cognitive Assessment","key":"10.1016\/j.rcsop.2022.100164_bb0265"},{"issue":"99","key":"10.1016\/j.rcsop.2022.100164_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19990","volume":"19","author":"Michie","year":"2015","journal-title":"Health Technol Assess"},{"issue":"1","key":"10.1016\/j.rcsop.2022.100164_bb0275","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12160-013-9486-6","article-title":"The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions","volume":"46","author":"Michie","year":"2013","journal-title":"Ann Behav Med"},{"issue":"8","key":"10.1016\/j.rcsop.2022.100164_bb0280","first-page":"693","article-title":"Behavior change techniques and their mechanisms of action: a synthesis of links described in published intervention literature","volume":"53","author":"Carey","year":"2018","journal-title":"Ann Behav Med"},{"key":"10.1016\/j.rcsop.2022.100164_bb0285","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1748-5908-7-37","article-title":"Validation of the theoretical domains framework for use in behaviour change and implementation research","volume":"7","author":"Cane","year":"2012","journal-title":"Implement Sci"},{"issue":"1","key":"10.1016\/j.rcsop.2022.100164_bb0290","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1748-5908-6-42","article-title":"The behaviour change wheel: a new method for characterising and designing behaviour change interventions","volume":"6","author":"Michie","year":"2011","journal-title":"Implement Sci"},{"issue":"2","key":"10.1016\/j.rcsop.2022.100164_bb0300","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap) \u2013 a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.rcsop.2022.100164_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"year":"2014","series-title":"The Behaviour Change Wheel: A Guide to Designing Interventions","author":"Michie","key":"10.1016\/j.rcsop.2022.100164_bb0310"}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276622000634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276622000634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T08:28:40Z","timestamp":1757406520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667276622000634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":60,"alternative-id":["S2667276622000634"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2022.100164","relation":{},"ISSN":["2667-2766"],"issn-type":[{"type":"print","value":"2667-2766"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A protocol for a randomized controlled trial comparing Sleepwell, EMPOWER, and treatment-as-usual for benzodiazepine receptor agonist discontinuation in older adults: the your answers when needing sleep in New Brunswick (YAWNS NB) study","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2022.100164","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100164"}}